Evidence map›Paper›PMID 42243384›Full record

ArticleAnnals of surgical oncology2026

Bilateral Wilms Tumor: Looking for the Best Surgical Strategy.

Marta Martos Rodríguez, Hélène Sudour-Bonnange, Hubert Ducou Le Pointe, Lauriane Lemelle, Jacinthe Bonneau-Lagacherie, Claudia Pasqualini, Cécile Boulanger, Anne Notz-Carrere, Ludovic Mansuy, Claire Pluchart and 10 more

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Marta Martos RodríguezPediatric Surgical Oncology Unit, Department of Pediatric Surgery, Vall d'Hebron University Hospital, Barcelona, Spain. marta.martosrodriguez@vallhebron.cat.
Hélène Sudour-BonnangePediatric Surgery Department, Department of Children and AYA Oncology, Centre Oscar Lambret, Lille, France.
Hubert Ducou Le PointePediatric Radiology Department, Sorbonne University, Assistance Publique Hôpitaux de Paris, Armand Trousseau Hospital, Paris, France.
Lauriane LemelleSIREDO Oncology Center, Institut Curie, Paris, France.
Jacinthe Bonneau-LagacherieUniversity Hospital of Rennes, Pediatric Oncology and Hematology, Rennes, France.
Claudia PasqualiniDepartment of Child and Adolescent Oncology, Gustave Roussy, Villejuif, France.
Cécile BoulangerCHU Toulouse, Toulouse, France.
Anne Notz-CarrereCHU Bordeaux, Bordeaux, France.
Ludovic MansuyPediatric Oncology and Hematology Department, University Hospital Center of Nancy, Nancy, France.
Claire PluchartDepartment of Paediatric Haematology and Oncology, Centre Hospitalo-Universitaire de Reims, Reims, France.
Julien RodCHU Caen Normandie, Caen, France.
Sarah JannierPediatric Oncology Department, University Hospital of Strasbourg, Strasbourg, France.
Nicolas SirventCHU Montpellier, Montpellier, France.
Dominique PlantazInstitut Gustave Roussy, GFAOP, Villejuif, France.
Sébastien KleinCHU Jean-Minjoz, Pediatric Oncology and Hematology, Besançon, France.
Leslie AndryService d'Oncologie et d'Hématologie Pédiatrique, CHU Amiens, Amiens, France.
Arnauld VerschuurPediatric Oncology Department, La Timone, Children's Hospital, Marseille, France.
Benoit DumontPediatric Oncology Department, Leon-Berard Institut, Lyon, France.
Georges AudryNeonatal and Visceral Pediatric Surgery Department, Sorbonne University, Assistance Publique Hôpitaux de Paris, Armand Trousseau Hospital, Paris, France.
Sabine IrtanNeonatal and Visceral Pediatric Surgery Department, Sorbonne University, Assistance Publique Hôpitaux de Paris, Armand Trousseau Hospital, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundManagement of bilateral Wilms tumor (BWT) to achieve complete tumor control and maintain good long-term renal function is challenging. Nephron-sparing surgery (NSS) allows preservation of renal parenchyma and reduces the risk of renal failure in selected cases. However, there is no standardized surgical strategy. This study analyzed the surgical management for patients included in the SIOP2001 trial and its outcomes.

methodsThis retrospective review analyzed French patients included in the SIOP 2001 protocol for synchronous BWT. Data regarding imaging, surgical strategy, complications, histology, oncologic outcomes, and renal function were collected.

resultsThe study included 96 patients (median age, 15 months; range, 0-143 months). They received surgery for 122 Wilms tumors, and 56 (45.9 %) kidneys benefited from NSS. Total nephrectomy (TN) was performed in 27/35 (77.1 %) and 33/76 (43.4 %) of the histologies non-sensitive to chemotherapy (stromal and diffuse anaplasia, respectively). For bilateral surgery, the study found a trend to more TNs, tumoral rupture, and death among the patients who had surgery in a single stage (p > 0.05). Tumor rupture was associated with higher tumoral volume (p < 0.05). In a review of preoperative images, vascular contact was the main factor associated with TN. Additional chemotherapy did not seem to significantly reduce this contact or the number of TNs in these patients.

conclusionWhenever possible, NSS should be prioritized for patients with BWT. In this study, the most limiting factor was contact with vascular structures. Additional chemotherapy for tumors with non-sensitive histology or extensive vascular contact had little impact on the final surgical strategy. Staged surgery should be considered as it appeared to reduce surgical morbidity.

Indexed as

Kidney NeoplasmsNephrectomyOrgan Sparing TreatmentsWilms TumorChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantInfant, NewbornMaleNephronsPrognosisRetrospective StudiesSurvival RateBilateral diseaseNephron-sparing surgeryOutcomeTotal nephrectomyWilms tumour

Identifiers

PMID42243384
PMCPMC13452865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.